Cargando…

Editorial: RNA Modification in Human Cancers: Roles and Therapeutic Implications

Detalles Bibliográficos
Autores principales:	Zhou, You, Huang, Tao, Li, Tianbao, Sun, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841760/ https://www.ncbi.nlm.nih.gov/pubmed/35173771 http://dx.doi.org/10.3389/fgene.2022.845744

Ejemplares similares

Editorial: Role of RNA Modification in Disease
por: Buratti, Emanuele, et al.
Publicado: (2019)

Editorial: RNA editing and modification in development and diseases
por: Li, Yanqiang, et al.
Publicado: (2022)

Editorial: RNA modifications and epitranscriptomics, Volume II
por: Chen, Kunqi, et al.
Publicado: (2023)

Editorial: Epigenetic regulation and non-histone post-translational modification in cancer
por: Luo, Jiang, et al.
Publicado: (2023)

Editorial: Computational Epitranscriptomics: Bioinformatic Approaches for the Analysis of RNA Modifications
por: Dassi, Erik, et al.
Publicado: (2020)

Editorial: Role of Epigenetic Modifications on Diet-Induced Metabolic Diseases
por: Vinciguerra, Manlio, et al.
Publicado: (2020)

Editorial: Role of RNA in Molecular Diagnostics of Cancer
por: Cho, William C. S., et al.
Publicado: (2020)

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
por: Rong, Dawei, et al.
Publicado: (2021)

Editorial: Biomedical application of DNA modifications
por: Mao, Fengbiao, et al.
Publicado: (2023)

Editorial: Implications of Ferroptosis-Related Genes to the Genetics of Cancer Development
por: Li, Manshan, et al.
Publicado: (2022)

Editorial: Applications of RNA-seq in cancer and tumor research
por: Lang, Jidong, et al.
Publicado: (2023)

Editorial: RNA-chromatin interactions: Biology, mechanism, disease and therapeutics
por: Mathiyalagan, Prabhu, et al.
Publicado: (2023)

The role of RNA modification in the generation of acquired drug resistance in glioma
por: Yan, Yu, et al.
Publicado: (2022)

Features of CFTR mRNA and implications for therapeutics development
por: Jackson, JaNise J., et al.
Publicado: (2023)

Shining a spotlight on m6A and the vital role of RNA modification in endometrial cancer: a review
por: Jin, Zujian, et al.
Publicado: (2023)

Editorial: Epigenetic and Transcriptional Dysregulations in Cancer and Therapeutic Opportunities
por: Ansari, Rais A., et al.
Publicado: (2022)

Editorial: Applications of Metagenomics in Studying Human Cancer
por: Huang, Guohua, et al.
Publicado: (2021)

Editorial: Perturbation of RNA Binding Protein Regulation in Cancer
por: Li, Yongsheng, et al.
Publicado: (2021)

The Identification and Analysis of mRNA–lncRNA–miRNA Cliques From the Integrative Network of Ovarian Cancer
por: Zhou, You, et al.
Publicado: (2019)

Long Noncoding RNA LINC00467: Role in Various Human Cancers
por: Wu, Di, et al.
Publicado: (2022)

Editorial: Cancer evolution: From biological insights to therapeutic opportunities
por: Davis, Andrew A., et al.
Publicado: (2022)

Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers
por: He, Chun-Ming, et al.
Publicado: (2022)

Editorial: Computational methods to analyze RNA data for human diseases
por: Ding, Pingjian, et al.
Publicado: (2023)

Editorial: RNA machines
por: Shirokikh, Nikolay E., et al.
Publicado: (2023)

Editorial: Epigenomics implication for economic traits in domestic animals
por: Zhao, Chunfang, et al.
Publicado: (2023)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects
por: Kaur, Mandeep, et al.
Publicado: (2022)

Editorial: DNA & RNA methylation: impact on cancer progression
por: Shukla, Vaibhav, et al.
Publicado: (2023)

Editorial: Epigenetics in Cancer: Mechanisms and Drug Development
por: Yuan, Huiqing, et al.
Publicado: (2022)

Editorial: Genetics and ontogeny in precision therapeutics for children
por: Chen, Feng, et al.
Publicado: (2023)

The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers
por: Zhang, Xun, et al.
Publicado: (2022)

RNA modification in cardiovascular disease: implications for therapeutic interventions
por: Wang, Cong, et al.
Publicado: (2023)

Editorial: Non-Coding RNA Mediated Post-Transcriptional Regulation in Human Diseases
por: Kumar, Santosh, et al.
Publicado: (2022)

Alteration of mRNA 5-Methylcytosine Modification in Neurons After OGD/R and Potential Roles in Cell Stress Response and Apoptosis
por: Jian, Huan, et al.
Publicado: (2021)

Research Progress for RNA Modifications in Physiological and Pathological Angiogenesis
por: Chen, Hui-Ming, et al.
Publicado: (2022)

RNA modification writers pattern in relation to tumor microenvironment and prognosis in prostate cancer
por: Cheng, Xu, et al.
Publicado: (2023)

Epigenetic modifications in chronic rhinosinusitis with and without nasal polyps
por: Li, Jing, et al.
Publicado: (2023)

The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
por: He, Wan, et al.
Publicado: (2022)

Biosynthesis and functions of sulfur modifications in tRNA
por: Shigi, Naoki
Publicado: (2014)

The Basis and Promise of Programmable RNA Editing and Modification
por: Lo, Nicholas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5oaa9s0ram776qgq743tt2es7s